Analysis of Reportable Segments
Ecolab Inc. operates in 3 segments: Global Industrial; Global Institutional & Specialty; and Global Healthcare & Life Sciences.
Segment Profit Margin
Ecolab Inc., profit margin by reportable segment
| Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | |
|---|---|---|---|---|---|
| Global Industrial | 16.35% | 18.56% | 15.34% | 14.06% | 14.80% |
| Global Institutional & Specialty | 14.00% | 9.00% | 19.91% | 19.73% | 20.77% |
| Global Healthcare & Life Sciences | 13.46% | 17.46% | — | — | — |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).
The segment profit margins between 2017 and 2021 reveal divergent performance trajectories and a significant structural shift in the reporting of business units. While one segment experienced growth and peak profitability during the middle of the period, another suffered a severe contraction before beginning a partial recovery.
- Global Industrial
- A general upward trend in profitability is observed, despite a slight dip in 2018. The margin increased from 14.80% in 2017 to a peak of 18.56% in 2020. Although a contraction to 16.35% occurred in 2021, the margin remained higher than the pre-2020 levels, indicating improved operational efficiency or pricing power over the five-year period.
- Global Institutional & Specialty
- This segment maintained relative stability between 2017 and 2019, with margins hovering around 20%. However, a sharp and significant decline occurred in 2020, where the profit margin dropped to 9.00%. A partial recovery was noted in 2021, with the margin rising to 14.00%, though it remained substantially below the historical levels seen prior to 2020.
- Global Healthcare & Life Sciences
- Reporting for this segment began in 2020 with an initial profit margin of 17.46%. A downward adjustment followed in 2021, with the margin decreasing to 13.46%, representing a reduction of 4.00 percentage points within the first two years of reported data.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Segment Profit Margin: Global Industrial
Ecolab Inc.; Global Industrial; segment profit margin calculation
| Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | |
|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||
| Operating income (loss) | 1,031,000) | 1,106,000) | 854,700) | 768,100) | 722,000) |
| Net sales | 6,304,900) | 5,959,900) | 5,569,900) | 5,462,400) | 4,878,500) |
| Segment Profitability Ratio | |||||
| Segment profit margin1 | 16.35% | 18.56% | 15.34% | 14.06% | 14.80% |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).
1 2021 Calculation
Segment profit margin = 100 × Operating income (loss) ÷ Net sales
= 100 × 1,031,000 ÷ 6,304,900 = 16.35%
The Global Industrial segment demonstrated a consistent upward trajectory in net sales and overall operating income from 2017 to 2021, although profitability margins experienced notable volatility, specifically peaking in 2020 before contracting in 2021.
- Revenue Growth Trends
- Net sales exhibited steady growth over the five-year period, rising from US$ 4,878,500 thousand in 2017 to US$ 6,304,900 thousand in 2021. The most pronounced year-over-year increase occurred between 2017 and 2018, followed by more moderate, incremental growth in subsequent years.
- Operating Income Performance
- Operating income showed a general increase from 2017 through 2020, climbing from US$ 722,000 thousand to a high of US$ 1,106,000 thousand. However, a divergence occurred in 2021, where operating income decreased to US$ 1,031,000 thousand despite the continued growth in net sales.
- Segment Profit Margin Dynamics
- The segment profit margin fluctuated between a low of 14.06% in 2018 and a peak of 18.56% in 2020. The significant expansion observed in 2020 indicates a period of high operational efficiency or favorable pricing. This was followed by a decline to 16.35% in 2021, suggesting that operating costs escalated more rapidly than revenue growth during that fiscal year.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Segment Profit Margin: Global Institutional & Specialty
Ecolab Inc.; Global Institutional & Specialty; segment profit margin calculation
| Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | |
|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||
| Operating income (loss) | 556,900) | 321,900) | 1,042,200) | 1,026,900) | 985,700) |
| Net sales | 3,978,200) | 3,577,200) | 5,235,500) | 5,204,500) | 4,744,900) |
| Segment Profitability Ratio | |||||
| Segment profit margin1 | 14.00% | 9.00% | 19.91% | 19.73% | 20.77% |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).
1 2021 Calculation
Segment profit margin = 100 × Operating income (loss) ÷ Net sales
= 100 × 556,900 ÷ 3,978,200 = 14.00%
The financial performance of the Global Institutional & Specialty segment is characterized by a period of stability and growth through 2019, followed by a severe contraction in 2020 and a partial recovery in 2021.
- Revenue Performance
- Net sales demonstrated a steady upward trend from 2017 to 2019, rising from US$ 4.74 billion to a peak of US$ 5.24 billion. A sharp decline occurred in 2020, with sales falling to US$ 3.58 billion, representing a substantial contraction. By 2021, a partial recovery was observed as net sales increased to US$ 3.98 billion.
- Operating Income Trajectory
- Operating income mirrored the revenue trend, increasing from US$ 985.7 million in 2017 to US$ 1.04 billion in 2019. The segment experienced a precipitous drop in 2020, with operating income falling to US$ 321.9 million. Although this figure rebounded to US$ 556.9 million in 2021, it remained significantly below pre-2020 levels.
- Profit Margin Volatility
- The segment profit margin remained consistently near 20% between 2017 and 2019, indicating stable operational efficiency. In 2020, the margin contracted sharply to 9.00%, reflecting the disproportionate impact of revenue loss relative to fixed costs. While the margin improved to 14.00% in 2021, it did not return to the baseline levels observed in the 2017-2019 period.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Segment Profit Margin: Global Healthcare & Life Sciences
Ecolab Inc.; Global Healthcare & Life Sciences; segment profit margin calculation
| Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | |
|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||
| Operating income (loss) | 160,900) | 207,600) | —) | —) | —) |
| Net sales | 1,195,400) | 1,189,100) | —) | —) | —) |
| Segment Profitability Ratio | |||||
| Segment profit margin1 | 13.46% | 17.46% | — | — | — |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).
1 2021 Calculation
Segment profit margin = 100 × Operating income (loss) ÷ Net sales
= 100 × 160,900 ÷ 1,195,400 = 13.46%
Between the fiscal years ending December 31, 2020, and December 31, 2021, the Global Healthcare & Life Sciences segment experienced a notable decline in operational profitability despite stable top-line performance.
- Revenue Performance
- Net sales remained relatively stagnant, showing a marginal increase from US$ 1,189.1 million in 2020 to US$ 1,195.4 million in 2021. This suggests that the segment maintained a consistent market position without significant growth in sales volume or pricing power during this period.
- Operating Income Trend
- A significant contraction in operating income was observed, with values falling from US$ 207.6 million in 2020 to US$ 160.9 million in 2021. This represents a decrease of approximately 22.5% in operating profit, indicating a sharp rise in operating expenses or cost of goods sold relative to revenue.
- Profit Margin Analysis
- The segment profit margin underwent a compression of 400 basis points, dropping from 17.46% in 2020 to 13.46% in 2021. This downward trend highlights a reduction in operational efficiency, as the segment was unable to translate its stable revenue into the same level of profitability achieved in the previous year.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Net sales
Ecolab Inc., net sales by reportable segment
US$ in thousands
| Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | |
|---|---|---|---|---|---|
| Global Industrial | 6,304,900) | 5,959,900) | 5,569,900) | 5,462,400) | 4,878,500) |
| Global Institutional & Specialty | 3,978,200) | 3,577,200) | 5,235,500) | 5,204,500) | 4,744,900) |
| Global Healthcare & Life Sciences | 1,195,400) | 1,189,100) | —) | —) | —) |
| Global Energy | —) | —) | 3,334,000) | 3,501,800) | 3,199,300) |
| Other | 1,226,900) | 1,093,300) | 907,500) | 877,600) | 823,500) |
| Corporate | 139,400) | 102,400) | —) | —) | —) |
| Subtotal at fixed currency | 12,844,800) | 11,921,900) | 15,046,900) | 15,046,300) | 13,646,200) |
| Effect of foreign currency translation | (111,700) | (131,700) | (140,600) | (378,100) | 192,100) |
| Consolidated reported GAAP | 12,733,100) | 11,790,200) | 14,906,300) | 14,668,200) | 13,838,300) |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).
Consolidated reported GAAP net sales exhibited a growth trajectory from 2017 to 2019, peaking at approximately 14.91 billion USD, before experiencing a significant contraction in 2020 to 11.79 billion USD. A partial recovery followed in 2021, with sales rising to 12.73 billion USD. This overall volatility is primarily attributed to the performance of specific reportable segments and structural changes in financial reporting.
- Global Industrial Segment Performance
- This segment demonstrates consistent and uninterrupted growth throughout the five-year period. Net sales increased from 4.88 billion USD in 2017 to 6.30 billion USD in 2021, establishing it as a primary driver of revenue stability and growth for the organization.
- Global Institutional & Specialty Volatility
- A period of steady growth was observed between 2017 and 2019, with sales reaching 5.24 billion USD. However, a sharp decline occurred in 2020, where sales dropped to 3.58 billion USD. While a recovery began in 2021, reaching 3.98 billion USD, the segment remained significantly below its 2019 peak.
- Structural Segment Reorganization
- The reporting structure underwent significant changes starting in 2020. The Global Energy segment, which reported 3.33 billion USD in 2019, ceased to be reported as a separate line item in 2020 and 2021. Conversely, the Global Healthcare & Life Sciences segment emerged in 2020 with 1.19 billion USD in net sales, remaining stable through 2021.
- Other and Corporate Revenue Trends
- The Other category showed a continuous upward trend, growing from 823.5 million USD in 2017 to 1.23 billion USD in 2021. Corporate net sales were first reported in 2020 at 102.4 million USD and increased to 139.4 million USD by the end of 2021.
- Foreign Currency Translation Impact
- Foreign currency translation provided a positive contribution of 192.1 million USD in 2017 but transitioned into a consistent headwind from 2018 through 2021. The negative impact peaked in 2018 at 378.1 million USD and persisted as a reductive factor on consolidated reported GAAP sales in subsequent years.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Operating income (loss)
Ecolab Inc., operating income (loss) by reportable segment
US$ in thousands
| Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | |
|---|---|---|---|---|---|
| Global Industrial | 1,031,000) | 1,106,000) | 854,700) | 768,100) | 722,000) |
| Global Institutional & Specialty | 556,900) | 321,900) | 1,042,200) | 1,026,900) | 985,700) |
| Global Healthcare & Life Sciences | 160,900) | 207,600) | —) | —) | —) |
| Global Energy | —) | —) | 379,100) | 358,500) | 338,500) |
| Other | 187,300) | 131,500) | 167,300) | 161,300) | 149,300) |
| Corporate | (318,600) | (347,500) | (409,100) | (307,100) | (208,600) |
| Subtotal at fixed currency | 1,617,500) | 1,419,500) | 2,034,200) | 2,007,700) | 1,986,900) |
| Effect of foreign currency translation | (18,900) | (23,800) | (20,400) | (60,700) | 32,900) |
| Consolidated reported GAAP | 1,598,600) | 1,395,700) | 2,013,800) | 1,947,000) | 2,019,800) |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).
Consolidated reported GAAP operating income exhibited a period of relative stability between 2017 and 2019, maintaining levels around US$ 2 billion, before experiencing a significant contraction in 2020 to US$ 1,395.7 million. A partial recovery was observed in 2021, with operating income rising to US$ 1,598.6 million, although this remained below pre-2020 levels.
- Global Industrial Segment Performance
- A consistent upward trajectory was observed from 2017 through 2020, with operating income increasing from US$ 722 million to a peak of US$ 1,106 million. This segment emerged as the primary contributor to operating profit by the end of the period, despite a slight moderation to US$ 1,031 million in 2021.
- Global Institutional and Specialty Volatility
- This segment demonstrated stability through 2019, peaking at US$ 1,042.2 million. However, a severe decline occurred in 2020, where operating income dropped to US$ 321.9 million. While a recovery trend began in 2021 with an increase to US$ 556.9 million, the segment did not return to its historical baseline.
- Segmental Structural Shifts
- A realignment in reportable segments is evident starting in 2020. The Global Energy segment, which provided steady income from 2017 to 2019 (peaking at US$ 379.1 million), ceased to be reported separately. Simultaneously, the Global Healthcare and Life Sciences segment was introduced in 2020 with US$ 207.6 million in operating income, which subsequently decreased to US$ 160.9 million in 2021.
- Corporate Costs and Currency Effects
- Corporate expenses remained a consistent drag on consolidated results, with annual losses ranging from US$ 208.6 million in 2017 to a peak of US$ 409.1 million in 2019. Additionally, the effect of foreign currency translation shifted from a positive contribution in 2017 to a persistent headwind from 2018 through 2021, consistently reducing the consolidated reported GAAP operating income.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?